TY - JOUR
T1 - Adiposity and the relationship between vitamin D and blood pressure
AU - Sulistyoningrum, Dian C.
AU - Gasevic, Danijela
AU - Green, Timothy J.
AU - Lear, Scott A.
AU - Devlin, Angela M.
N1 - Funding Information:
This study was supported by an operating grant from the Canadian Health Institute of Research (to A.M.D.). D.C. Sulistyoningrum was supported by a graduate studentship from the Child and Family Research Institute . S.A. Lear is a Pfizer/Heart and Stroke Foundation of Canada Chair in Cardiovascular Disease Prevention Research at St. Paul’s Hospital. A.M. Devlin is supported by an Investigatorship from the Child and Family Research Institute .
PY - 2013/12
Y1 - 2013/12
N2 - Objective Circulating vitamin D (25OHD) concentrations are negatively associated with blood pressure (BP) but little is known about the mechanisms for this relationship. Adiposity is positively associated with BP and inversely with circulating 25OHD concentrations but no studies have assessed the relationship between plasma 25OHD and adiposity on BP. The goal of this study is to investigate if the association between plasma 25OHD and BP is mediated by adiposity. Materials/Methods The relationship between plasma 25OHD, systolic and diastolic BP, and adiposity [BMI, waist circumference, visceral adipose tissue (VAT)] was assessed in a multi-ethnic cross-sectional study of Aboriginal (n = 151), Chinese (n = 190), European (n = 170), and South Asian (n = 176) participants by linear regression models. Results Plasma 25OHD concentrations were negatively associated with systolic (standardized B = - 0.191, P < 0.001) and diastolic BP (standardized B = - 0.196, P < 0.001) in models adjusted for age, sex, ethnicity, family history of CVD, smoking status, alcohol consumption, and physical activity. The negative relationship between plasma 25OHD concentrations and systolic and diastolic BP was attenuated after the addition of BMI, waist circumference, and VAT to the models, but the relationship remained significant. Plasma 25OHD concentrations accounted for 0.7% and 0.8% of the variance in systolic and diastolic BP, respectively. Conclusion These findings suggest that the relationship between vitamin D and BP is independent of adiposity. Further studies are required to determine the mechanisms by which vitamin D affects BP.
AB - Objective Circulating vitamin D (25OHD) concentrations are negatively associated with blood pressure (BP) but little is known about the mechanisms for this relationship. Adiposity is positively associated with BP and inversely with circulating 25OHD concentrations but no studies have assessed the relationship between plasma 25OHD and adiposity on BP. The goal of this study is to investigate if the association between plasma 25OHD and BP is mediated by adiposity. Materials/Methods The relationship between plasma 25OHD, systolic and diastolic BP, and adiposity [BMI, waist circumference, visceral adipose tissue (VAT)] was assessed in a multi-ethnic cross-sectional study of Aboriginal (n = 151), Chinese (n = 190), European (n = 170), and South Asian (n = 176) participants by linear regression models. Results Plasma 25OHD concentrations were negatively associated with systolic (standardized B = - 0.191, P < 0.001) and diastolic BP (standardized B = - 0.196, P < 0.001) in models adjusted for age, sex, ethnicity, family history of CVD, smoking status, alcohol consumption, and physical activity. The negative relationship between plasma 25OHD concentrations and systolic and diastolic BP was attenuated after the addition of BMI, waist circumference, and VAT to the models, but the relationship remained significant. Plasma 25OHD concentrations accounted for 0.7% and 0.8% of the variance in systolic and diastolic BP, respectively. Conclusion These findings suggest that the relationship between vitamin D and BP is independent of adiposity. Further studies are required to determine the mechanisms by which vitamin D affects BP.
KW - Adiposity
KW - Blood Pressure
KW - Vitamin D
UR - http://www.scopus.com/inward/record.url?scp=84887996585&partnerID=8YFLogxK
U2 - 10.1016/j.metabol.2013.07.009
DO - 10.1016/j.metabol.2013.07.009
M3 - Article
C2 - 23987237
AN - SCOPUS:84887996585
SN - 0026-0495
VL - 62
SP - 1795
EP - 1802
JO - Metabolism: Clinical and Experimental
JF - Metabolism: Clinical and Experimental
IS - 12
ER -